Barclays
ELAN icon

Barclays’s Elanco Animal Health ELAN Stock Holding History

Barclays’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$488K – 4990
2024
Q1 		$488K Hold
30,000
– – ﹤0.01% 3610
2023
Q4 		$447K Buy
+30,000
New +$340K ﹤0.01% 3948
2021
Q1 		– Sell
-6,100
Closed -$187K – 4818
2020
Q4 		$187K Hold
6,100
– – ﹤0.01% 3795
2020
Q3 		$170K Sell
6,100
-27,400
-82% -$694K ﹤0.01% 3943
2020
Q2 		$719K Sell
33,500
-29,800
-47% -$658K ﹤0.01% 3043
2020
Q1 		$1.42M Buy
63,300
+20,600
+48% +$564K ﹤0.01% 2607
2019
Q4 		$1.26M Sell
42,700
-25,100
-37% -$682K ﹤0.01% 3463
2019
Q3 		$1.8M Buy
67,800
+67,600
+33,800% +$2.03M ﹤0.01% 3000
2019
Q2 		$7K Buy
+200
New +$6.49K ﹤0.01% 6628

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Barclays's ELAN Position: Q2 2026 in Review

Barclays reduced its Elanco Animal Health (ELAN) stake by 34% in Q2 2026, selling an estimated $2.09M and leaving 177,252 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Barclays first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $29M in Q3 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Barclays held 177,252 shares of Elanco Animal Health worth $4.36M as of Q2 2026.
  • Barclays sold 90,330 Elanco Animal Health shares in Q2 2026, an estimated $2.09M.
  • Elanco Animal Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1924 holding.
  • Barclays first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
  • Barclays's Elanco Animal Health position peaked at $29M in Q3 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.